Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",21756,196,1.80 [1.42-2.28],1.0844600519015143e-06
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",22964,246,1.68 [1.36-2.07],1.3830942245509896e-06
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22695,1755,1.61 [1.49-1.75],6.715027031090319e-31
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Candidiasis,22972,550,1.69 [1.46-1.94],3.814170770374524e-13
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22218,4220,1.48 [1.40-1.56],2.104227909192648e-46
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22166,4294,1.55 [1.47-1.63],1.7013460068203506e-60
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22681,1430,1.50 [1.37-1.65],2.644508349700312e-18
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,22874,126,2.11 [1.61-2.76],4.5234391927974425e-08
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20164,1300,1.85 [1.69-2.03],1.2636411229691964e-39
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19459,1583,2.02 [1.87-2.20],3.3990847093705325e-64
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,18956,345,2.24 [1.89-2.64],3.708211051188988e-21
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14950,2741,1.76 [1.65-1.89],4.229838835959357e-63
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,18891,498,2.05 [1.77-2.37],2.270905262071032e-22
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22946,1695,1.50 [1.38-1.63],4.0777485083292385e-21
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Mycoses,23067,645,1.70 [1.50-1.94],9.215619709082493e-16
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22189,1249,1.72 [1.57-1.89],4.784990721868094e-30
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,22996,1436,1.73 [1.59-1.89],5.75883622778735e-35
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21497,246,1.72 [1.39-2.12],4.257109866903837e-07
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23126,67,1.30 [0.84-2.02],0.2437582477221461
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22814,1254,1.74 [1.58-1.91],2.5992314757828555e-31
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22827,79,1.21 [0.80-1.83],0.3666429688676262
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23059,141,1.46 [1.09-1.95],0.0114498886472141
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23035,117,1.44 [1.05-1.99],0.0243404728106795
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21437,497,1.91 [1.65-2.21],3.7532284744296224e-18
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,21248,308,1.61 [1.32-1.95],2.2238518647291034e-06
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,21391,140,1.78 [1.36-2.34],3.26592398579103e-05
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23111,52,2.00 [1.29-3.10],0.0017932101891508
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23058,170,1.50 [1.14-1.95],0.0031549154396236
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Viral warts,22943,55,1.72 [1.10-2.71],0.0181434860443093
TGFA,Protransforming growth factor alpha,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],22964,76,1.50 [1.01-2.24],0.0457081382878818
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Benign lipomatous neoplasm,22833,266,0.85 [0.66-1.08],0.1824671595025732
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23042,40,0.87 [0.47-1.61],0.6585301633959162
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23027,44,0.66 [0.35-1.22],0.1833703481537142
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,11015,86,1.00 [0.65-1.53],0.99993622204616
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22657,1660,1.09 [1.00-1.20],0.0626152406143109
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Benign neoplasm of meninges,23110,64,1.52 [0.99-2.33],0.0574027880783616
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23032,80,1.91 [1.35-2.71],0.0002711198365615
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23100,120,1.37 [0.99-1.88],0.055124911325046
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Benign neoplasm of ovary,12040,80,1.00 [0.66-1.52],0.9961073706521596
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23086,436,1.10 [0.92-1.32],0.3009288796807395
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Benign neoplasm: Caecum,23091,380,1.01 [0.83-1.23],0.9189627040054064
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",22977,88,0.80 [0.52-1.23],0.3067367333324849
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Benign neoplasm: Descending colon,23082,251,0.91 [0.71-1.16],0.4425244756755295
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Benign neoplasm: Rectum,23041,408,1.01 [0.83-1.22],0.9502963892422726
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,22970,673,1.13 [0.98-1.30],0.093942692099597
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23068,534,1.17 [1.00-1.37],0.0556927372571607
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Carcinoma in situ of breast,9043,49,0.90 [0.52-1.56],0.7083864646673332
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",9086,66,1.04 [0.66-1.64],0.8604817866144646
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",16497,71,1.41 [0.92-2.17],0.1172021453823395
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",16527,101,1.21 [0.83-1.75],0.3270680666480204
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23069,127,1.19 [0.86-1.66],0.2872370214086063
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Haemangioma, any site",23070,124,1.21 [0.87-1.68],0.2656288737885662
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Leiomyoma of uterus,11777,170,0.87 [0.64-1.17],0.3561997333194315
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Lung cancer and mesothelioma,14632,478,1.78 [1.52-2.07],2.6083173444005424e-13
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Lymphoid leukaemia,16498,72,1.26 [0.81-1.96],0.3040252686948667
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16653,227,1.26 [0.99-1.61],0.0602176736900757
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",16744,318,1.10 [0.89-1.36],0.3939655162237697
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",9168,106,1.20 [0.84-1.69],0.3162426097448297
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",16536,110,1.39 [1.00-1.95],0.0526800823449824
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",16573,147,1.78 [1.37-2.30],1.2196363425191864e-05
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",16548,122,1.41 [1.03-1.93],0.0335516590543985
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",9151,89,1.17 [0.80-1.71],0.4268423231580323
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",16553,127,0.87 [0.61-1.24],0.4421197655783082
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",8335,971,0.96 [0.84-1.09],0.4990898682560266
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",16560,134,0.72 [0.50-1.04],0.0778604909829867
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",16518,92,1.53 [1.08-2.18],0.0182191294896325
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16574,148,0.95 [0.69-1.32],0.7772825563671182
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Melanocytic naevi,22980,186,1.18 [0.90-1.55],0.2237199679655347
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Melanocytic naevi of trunk,23097,78,1.38 [0.92-2.07],0.1142192987723386
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Melanoma in situ,16479,111,1.26 [0.89-1.79],0.1849559379218863
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16549,123,1.26 [0.90-1.75],0.1817267821684498
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16627,201,1.47 [1.15-1.88],0.0023729799097571
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",16753,327,1.32 [1.09-1.59],0.0040543602111782
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16554,128,1.64 [1.21-2.22],0.0012490536994858
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,Other benign neoplasms of skin,22952,166,1.03 [0.77-1.39],0.845157142883552
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",17914,1488,1.05 [0.95-1.16],0.3701303570283843
TGFA,Protransforming growth factor alpha,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",17999,1573,1.07 [0.97-1.18],0.1665754018074667
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22815,396,1.11 [0.92-1.34],0.2817951754129978
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,20807,166,3.10 [2.50-3.85],8.328804712963374e-25
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22490,71,1.65 [1.11-2.47],0.0142963488445718
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22360,3502,1.67 [1.57-1.77],2.6979869573567693e-66
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,21406,72,1.95 [1.34-2.84],0.0004477824161133
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22652,64,2.21 [1.52-3.21],3.2528157722525007e-05
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22609,1968,1.79 [1.66-1.93],1.0398641529031299e-53
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22607,1966,1.79 [1.66-1.93],8.633874375505906e-54
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,20757,116,1.08 [0.75-1.55],0.6769777531798324
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22762,1428,1.75 [1.60-1.91],3.257579108619681e-36
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,22700,112,1.64 [1.19-2.26],0.0027364575242831
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22495,76,2.56 [1.84-3.57],2.9214664134746576e-08
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22496,77,1.19 [0.78-1.82],0.4147197045441184
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,22947,359,1.76 [1.48-2.09],1.8785589371329068e-10
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,22996,39,1.97 [1.19-3.25],0.0084176588083686
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",22884,296,1.55 [1.27-1.90],1.99282560490312e-05
TGFA,Protransforming growth factor alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,21470,136,1.59 [1.19-2.14],0.0019034426972741
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15463,417,2.71 [2.36-3.12],6.127345331452497e-44
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21618,105,1.38 [0.98-1.95],0.0650448865949986
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21627,114,1.46 [1.06-2.03],0.0218001882146922
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,15118,72,2.31 [1.63-3.26],2.301051699738284e-06
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21478,65,2.05 [1.42-2.97],0.0001433484354857
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,20691,315,1.40 [1.15-1.71],0.000755897939821
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",22329,955,1.51 [1.35-1.69],4.417010940567447e-13
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,21856,482,1.22 [1.03-1.45],0.0188806110660124
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,21588,214,1.10 [0.84-1.42],0.4924093801449861
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,22841,1428,1.24 [1.12-1.36],1.377839421344428e-05
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19456,1382,1.28 [1.16-1.41],1.0474306333622035e-06
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",15138,92,1.75 [1.23-2.48],0.0019566199162998
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20829,100,1.13 [0.78-1.65],0.5108948884141962
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15411,365,2.02 [1.71-2.37],3.0217927666670814e-17
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,15103,57,2.07 [1.36-3.15],0.0007455272088958
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19638,4592,1.28 [1.21-1.35],1.2187633443078588e-18
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,15312,266,2.30 [1.90-2.79],1.998381982747001e-17
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15758,712,1.94 [1.72-2.19],9.676494071958662e-27
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23066,369,1.95 [1.65-2.29],1.5900534511551726e-15
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,22856,159,2.25 [1.77-2.86],2.9527013282347324e-11
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,15200,154,1.72 [1.29-2.27],0.0001712553033251
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",15127,81,2.79 [2.01-3.87],8.978013990391773e-10
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22485,1756,1.32 [1.21-1.43],2.7793347960331513e-10
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15428,382,2.69 [2.30-3.14],6.271038141681509e-36
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15477,431,2.85 [2.47-3.28],4.6696182477927677e-48
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15914,868,1.48 [1.31-1.67],3.3832499683830323e-10
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,15223,177,1.59 [1.22-2.07],0.0006873645141372
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,22846,149,2.34 [1.83-2.98],8.677210490917747e-12
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,15941,895,1.67 [1.49-1.87],2.4559507133358947e-19
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15705,659,1.70 [1.49-1.94],5.685759418187369e-15
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,20456,80,2.16 [1.52-3.06],1.7649554227326037e-05
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21475,6429,1.36 [1.30-1.43],5.153878844685477e-42
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20788,59,1.28 [0.80-2.06],0.2968731992399889
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20777,48,0.95 [0.55-1.67],0.8661163430539532
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22942,1909,1.19 [1.10-1.30],4.149266759925274e-05
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22940,1907,1.19 [1.10-1.30],4.279549930891408e-05
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20795,66,1.93 [1.30-2.87],0.0010228819682049
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,22769,1131,1.20 [1.08-1.34],0.0009070312998056
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",17284,2238,1.86 [1.74-1.99],4.425568020281473e-72
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23110,317,2.41 [2.04-2.84],1.799268951510849e-25
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,21505,131,1.46 [1.07-1.97],0.0156005634324945
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21759,121,1.32 [0.95-1.82],0.0938527427106593
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,21803,165,1.08 [0.81-1.45],0.5937452515509548
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",15246,200,1.71 [1.35-2.19],1.3247102299222448e-05
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20326,184,2.11 [1.67-2.67],3.044435903374118e-10
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2477,100,2.07 [1.51-2.83],5.294266721803689e-06
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2646,311,1.42 [1.18-1.72],0.0002782961642558
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20224,82,3.18 [2.36-4.28],2.1623037311415422e-14
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2450,76,2.68 [1.94-3.72],2.923363964684746e-09
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22279,2137,1.51 [1.40-1.63],6.173245812033746e-27
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22005,631,1.54 [1.35-1.77],4.51074052507621e-10
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,20827,451,1.56 [1.34-1.83],3.1160879355500973e-08
TGFA,Protransforming growth factor alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,16169,1123,1.97 [1.78-2.17],2.1963134164816177e-42
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",22989,302,1.35 [1.10-1.65],0.0044747157370537
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21628,270,1.63 [1.34-1.98],8.400109152543883e-07
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Angina pectoris,19963,1569,1.44 [1.32-1.57],6.332092010980143e-16
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Aortic aneurysm,21734,376,1.50 [1.26-1.78],4.454358297432768e-06
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21443,85,2.37 [1.76-3.19],1.595243385895315e-08
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21649,291,1.92 [1.61-2.30],8.413970632942642e-13
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11708,2841,1.46 [1.37-1.57],1.727782409644768e-28
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,AV-block,17567,683,1.39 [1.21-1.60],3.0121501711277693e-06
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23040,573,1.26 [1.08-1.47],0.0029717218047898
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Cardiac arrest,9135,268,2.16 [1.76-2.63],5.49438293254897e-14
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Cardiomyopathy,17089,205,1.38 [1.07-1.77],0.0128397194694948
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",16996,112,1.82 [1.33-2.49],0.0001915949608669
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23120,81,2.04 [1.45-2.86],4.125984569392227e-05
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Conduction disorders,18436,1552,1.42 [1.30-1.56],3.90616527431248e-14
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21132,2762,1.38 [1.29-1.48],2.061791456537328e-21
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18553,8894,1.26 [1.21-1.31],1.0486582807438142e-29
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21559,332,1.42 [1.17-1.72],0.0003975528003488
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Endocarditis,16987,103,1.46 [1.03-2.08],0.0350999807071023
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22836,1665,1.67 [1.54-1.81],3.614679203509315e-34
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Hypertension,19795,7913,1.28 [1.23-1.34],2.671229803560128e-31
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19814,7932,1.28 [1.23-1.34],1.020652010478516e-31
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"Hypertension, portal",22950,96,2.01 [1.46-2.77],2.1676286556004945e-05
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12141,259,1.93 [1.58-2.35],6.060747937538605e-11
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12091,209,3.32 [2.84-3.89],6.73689892131834e-51
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Hypotension,22943,1647,1.45 [1.33-1.58],2.3665126713695118e-17
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,21823,149,1.10 [0.81-1.50],0.5284295975895352
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21303,2909,1.35 [1.26-1.44],1.0150419552232124e-18
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22603,802,1.38 [1.22-1.56],3.7323803249711626e-07
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Left bundle-branch block,17410,526,1.42 [1.21-1.66],1.3643579675574732e-05
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22435,1058,1.33 [1.19-1.48],2.817972758041683e-07
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19304,910,1.46 [1.30-1.63],1.3744814312313059e-10
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",22994,188,1.45 [1.13-1.86],0.0031807609553231
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23085,407,1.39 [1.16-1.65],0.0002741664059635
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Oesophageal varices,21293,66,1.85 [1.23-2.78],0.0033262614067393
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Other aneurysm,21463,105,1.32 [0.93-1.86],0.1173493981794611
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Other arrhythmias,17481,597,1.21 [1.04-1.41],0.014448274739083
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21489,131,2.36 [1.86-3.00],1.6445291968221286e-12
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21682,324,1.81 [1.52-2.16],3.123269166896056e-11
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,17110,226,1.62 [1.29-2.03],3.9163071229795565e-05
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Other disorders of veins,21345,118,1.56 [1.14-2.14],0.0053638900741696
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,21275,48,1.24 [0.74-2.09],0.4132403445493919
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,21062,91,1.20 [0.81-1.78],0.3675960588693315
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,21405,178,1.31 [1.00-1.72],0.0471896993907979
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18348,1464,1.60 [1.46-1.74],1.3917611345857783e-24
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,21356,60,2.09 [1.41-3.09],0.0002395753339988
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22089,731,1.67 [1.48-1.88],8.533911232240707e-17
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22346,529,1.91 [1.66-2.20],7.454192646244815e-20
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",21951,980,1.40 [1.25-1.57],4.146616852793828e-09
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9281,414,1.61 [1.34-1.92],2.869052807832073e-07
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21916,593,1.91 [1.68-2.17],1.0981532400907845e-23
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21646,419,1.28 [1.08-1.53],0.0054404186680307
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22421,604,1.25 [1.08-1.46],0.0029184546432399
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23024,976,1.51 [1.35-1.68],3.706597738410499e-13
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Right bundle-branch block,17391,507,1.70 [1.46-1.98],8.660446591448499e-12
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22339,522,1.93 [1.67-2.22],4.5251598056884944e-20
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,21240,269,1.75 [1.43-2.14],5.067413793383117e-08
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22587,913,1.33 [1.18-1.50],1.93351136436299e-06
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22572,952,1.34 [1.20-1.51],5.472802203550104e-07
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,21789,58,1.59 [1.03-2.46],0.0370666419580718
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21465,107,1.13 [0.78-1.62],0.5264008421024042
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22127,326,1.38 [1.14-1.68],0.0010432522468532
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21707,330,1.31 [1.08-1.59],0.0064222325625197
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Varicose veins,21743,516,1.10 [0.93-1.30],0.2626955944796523
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,21381,125,1.71 [1.27-2.29],0.0003371517845891
TGFA,Protransforming growth factor alpha,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22847,946,1.23 [1.09-1.38],0.0007207226684172
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23041,333,1.27 [1.04-1.54],0.0172592351363348
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19753,1380,1.25 [1.13-1.38],1.0267357644858577e-05
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,Any mental disorder,22593,4220,1.28 [1.21-1.35],6.893860449000872e-18
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23013,393,1.29 [1.08-1.54],0.0051956917946674
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19827,1454,1.29 [1.17-1.41],2.452570567680741e-07
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18458,85,1.28 [0.86-1.90],0.2175616360576871
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,Smoking dependency,22615,1179,1.54 [1.40-1.69],1.5879316408458777e-19
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19827,1454,1.44 [1.32-1.57],2.289415720497743e-16
TGFA,Protransforming growth factor alpha,Chapter V Mental and behavioural disorders,Vascular dementia,22226,232,1.29 [1.02-1.63],0.0363904416579961
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Alzheimer disease,23122,589,1.23 [1.06-1.43],0.0072885711566641
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",14151,112,1.69 [1.22-2.34],0.001596786853225
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Bell's palsy,21266,88,1.16 [0.78-1.72],0.4617169439152072
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21674,496,1.01 [0.85-1.19],0.931684255631808
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Cerebral cysts,22668,248,1.29 [1.02-1.62],0.0328959409208007
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23048,414,1.42 [1.20-1.68],5.464432789066871e-05
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,22270,73,0.86 [0.54-1.37],0.5207639874350039
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23105,68,1.39 [0.90-2.14],0.1333866240653694
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22504,84,1.34 [0.91-1.99],0.1425598149601602
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Epilepsy,21605,304,1.20 [0.97-1.48],0.097019051425034
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22660,1359,1.24 [1.12-1.37],2.376563103143588e-05
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23068,924,1.08 [0.96-1.23],0.2150545273893982
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22459,3462,1.31 [1.23-1.39],1.0197433348261636e-17
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Generalized epilepsy,22743,53,1.00 [0.60-1.69],0.987466110233407
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Hemiplegia,22974,340,1.46 [1.22-1.76],5.858279871154901e-05
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Hydrocephalus,22493,73,1.46 [0.98-2.19],0.0630073874508699
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23109,72,1.39 [0.92-2.11],0.1152437408143609
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21245,67,1.25 [0.81-1.95],0.3172440902565404
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21252,74,0.89 [0.57-1.41],0.6284342594818978
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Memory loss,21973,142,1.27 [0.94-1.73],0.1213252957869491
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Migraine,21585,284,1.24 [1.00-1.54],0.0528574857554867
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23076,260,1.28 [1.03-1.61],0.0296146877614132
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Motor neuron disease,14238,175,1.04 [0.77-1.40],0.7829412638632142
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,22989,60,1.07 [0.67-1.72],0.7701358143654743
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22417,1239,1.14 [1.03-1.27],0.0127282663586809
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Neurological diseases,21634,4378,1.19 [1.12-1.26],1.3719800280560292e-09
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22520,323,1.20 [0.98-1.47],0.0782177326068361
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21608,430,1.21 [1.01-1.44],0.0351614163457084
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23045,356,1.67 [1.39-1.99],2.0454257664565515e-08
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,17277,975,1.26 [1.12-1.42],0.0001041591060046
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22506,86,1.16 [0.78-1.73],0.4544355693750037
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22582,162,1.40 [1.06-1.84],0.0170269805645149
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,22378,234,1.32 [1.04-1.67],0.0199342234056668
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21277,99,1.16 [0.80-1.69],0.4237584962440125
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Other headache syndromes,21354,53,0.96 [0.57-1.63],0.8849553444910049
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Other neurological diseases,23005,585,1.29 [1.11-1.50],0.0007286058563522
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Other sleep disorders,21819,518,1.27 [1.08-1.49],0.0035832153015349
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Parkinson's disease,23089,686,1.02 [0.88-1.19],0.749908218637347
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22465,45,1.33 [0.78-2.26],0.2993914309399921
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Restless leg syndrome,23123,107,1.20 [0.85-1.71],0.3040053189198195
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Sleep apnoea,22892,440,1.34 [1.13-1.59],0.000919302702965
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Small fibre neuropathy,22749,60,1.34 [0.84-2.14],0.2229240964145583
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23111,204,0.97 [0.74-1.27],0.8248510941911498
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21249,71,0.86 [0.54-1.37],0.5253047628975751
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23122,595,1.24 [1.07-1.44],0.0041320087663824
TGFA,Protransforming growth factor alpha,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),22165,226,1.30 [1.02-1.65],0.0339384534159971
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22467,156,1.40 [1.05-1.85],0.0201433935838424
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22662,564,1.23 [1.05-1.44],0.0086812568322333
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22868,269,1.78 [1.46-2.18],1.7202412625507315e-08
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,21893,68,0.76 [0.46-1.25],0.2809309553277593
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,21864,39,0.94 [0.50-1.77],0.859335312421606
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23002,73,1.30 [0.85-1.97],0.2203409332692941
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,22801,223,1.21 [0.95-1.55],0.1294866787798321
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2454,77,2.69 [1.94-3.73],2.842911087757975e-09
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,3027,114,1.85 [1.38-2.48],3.5692808897627364e-05
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22421,110,1.27 [0.90-1.79],0.1792952815849099
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22823,1431,1.14 [1.04-1.26],0.0079954677040007
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22713,888,1.05 [0.93-1.19],0.4378751449621958
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22131,306,1.06 [0.85-1.31],0.6254751131548182
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23046,948,1.10 [0.97-1.24],0.1341690361748174
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23116,81,1.37 [0.93-2.03],0.1155882160808671
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,22973,875,1.12 [0.98-1.27],0.0885319932851057
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23081,503,1.17 [0.99-1.38],0.0653345249425221
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23003,225,1.30 [1.02-1.65],0.0331067739619971
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,21926,101,1.24 [0.86-1.78],0.2508154130454167
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,21925,100,1.19 [0.82-1.71],0.3605394407281047
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,21902,77,1.06 [0.69-1.63],0.795889374138808
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,22988,1016,1.06 [0.94-1.19],0.3616884818150037
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22240,268,0.91 [0.71-1.15],0.425302266621972
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22169,71,1.30 [0.85-1.99],0.2252785830690918
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,22703,125,0.97 [0.69-1.37],0.8668533501640461
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,22969,391,1.21 [1.01-1.46],0.0429223800806723
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22317,219,0.92 [0.70-1.19],0.513422564512342
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,22921,143,1.27 [0.94-1.72],0.1247794654614666
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22652,680,1.15 [1.00-1.33],0.0479520916773484
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22474,163,1.38 [1.04-1.82],0.0250543018386281
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20646,3254,1.17 [1.09-1.25],3.0921533205801827e-06
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,22923,345,1.17 [0.96-1.43],0.118432540399775
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23108,188,1.29 [0.99-1.67],0.0616003123691994
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22365,540,1.09 [0.92-1.28],0.3121195921965107
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,22669,91,1.00 [0.67-1.49],0.9848009334013156
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23107,72,1.34 [0.88-2.03],0.1750444813693469
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,21956,131,0.93 [0.66-1.30],0.659703991701825
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,21999,174,1.06 [0.80-1.42],0.672991665273039
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,21554,162,1.17 [0.87-1.56],0.2993570032701045
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22161,63,0.96 [0.59-1.57],0.8821195729216101
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",21466,74,0.77 [0.48-1.24],0.277770124698406
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22083,111,1.08 [0.76-1.55],0.6556824867436482
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22266,294,1.16 [0.93-1.44],0.1913534718218329
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,21985,160,0.96 [0.70-1.30],0.7717069437706616
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,21488,96,0.98 [0.65-1.46],0.9137637865527236
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,21520,128,1.14 [0.82-1.60],0.4321362608199729
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20145,2753,1.18 [1.10-1.27],3.3652373437830985e-06
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,21917,92,0.77 [0.50-1.17],0.2211518832121802
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22825,514,1.33 [1.13-1.55],0.0004213826671008
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22392,81,1.15 [0.76-1.73],0.5035994061442712
TGFA,Protransforming growth factor alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22522,211,1.40 [1.10-1.79],0.0062694153661139
TGFA,Protransforming growth factor alpha,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,22897,111,1.03 [0.72-1.48],0.8624011042930857
TGFA,Protransforming growth factor alpha,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23076,139,1.19 [0.88-1.63],0.2633335427289555
TGFA,Protransforming growth factor alpha,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,22988,117,1.01 [0.71-1.43],0.9677928229657556
TGFA,Protransforming growth factor alpha,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,22851,65,0.91 [0.56-1.48],0.7014406800631772
TGFA,Protransforming growth factor alpha,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,22857,71,1.22 [0.79-1.89],0.36543539197627
TGFA,Protransforming growth factor alpha,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23015,1251,1.24 [1.12-1.38],4.699178990132076e-05
TGFA,Protransforming growth factor alpha,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,22710,946,1.24 [1.10-1.40],0.0003282437160182
TGFA,Protransforming growth factor alpha,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,21920,156,1.19 [0.88-1.61],0.2482698794069744
TGFA,Protransforming growth factor alpha,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,21855,91,1.11 [0.75-1.65],0.5946520559664643
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Acute pharyngitis,22930,68,1.17 [0.75-1.83],0.4950291296317958
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23050,188,1.27 [0.98-1.65],0.0734030983835888
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,22924,62,2.03 [1.37-3.00],0.0004288050581294
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,All influenza,20444,157,2.09 [1.62-2.69],1.1791301566060567e-08
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),20441,154,2.09 [1.62-2.70],1.5629041366134793e-08
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Allergic asthma (mode),14257,103,1.34 [0.92-1.95],0.1293578941573978
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Allergic rhinitis,23019,235,0.95 [0.73-1.22],0.6706341105914602
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15483,1721,1.51 [1.38-1.65],6.528310044331279e-20
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15852,1698,1.48 [1.35-1.62],8.626051765105796e-18
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22606,179,1.72 [1.35-2.20],1.139728525303096e-05
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",20392,105,1.81 [1.31-2.49],0.000278275828319
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Bronchiectasis,19379,516,2.07 [1.80-2.39],1.7797700074540932e-24
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",18936,73,2.43 [1.72-3.42],3.9344607148739e-07
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22000,3137,1.49 [1.40-1.58],2.859039661091441e-36
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",21901,72,1.49 [0.99-2.24],0.0542677415106357
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Chronic sinusitis,21965,136,1.43 [1.06-1.93],0.0200540948294071
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22836,1638,1.73 [1.60-1.87],1.1886062993766853e-42
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Deviated nasal septum,21910,81,0.81 [0.52-1.27],0.3680207371493186
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,20980,6112,1.41 [1.34-1.47],6.325483302041573e-47
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22166,337,1.01 [0.82-1.24],0.9536107871319748
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Early onset COPD,21304,106,1.73 [1.28-2.35],0.0003674110729961
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Emphysema,19298,435,1.91 [1.65-2.22],1.289255950375083e-17
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21820,453,1.75 [1.50-2.05],1.057919505379775e-12
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22866,2579,1.74 [1.63-1.85],3.3410755032045904e-61
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Interstitial lung disease,21863,496,1.70 [1.46-1.97],3.8713908614232595e-12
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Later onset COPD,22610,1532,1.74 [1.60-1.88],1.279550177558098e-40
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23106,500,1.60 [1.37-1.86],1.3328199625715726e-09
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Nasal polyp,21927,98,1.64 [1.17-2.30],0.0036961552250824
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22840,1302,1.70 [1.55-1.86],2.0684455876759485e-29
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Other diseases of pleura,22833,2681,1.55 [1.45-1.66],1.1172111650368094e-38
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22578,749,1.12 [0.98-1.28],0.1080233522591503
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Other pleural conditions,20219,67,2.26 [1.54-3.31],3.087665071068627e-05
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23003,594,1.64 [1.43-1.88],1.4077299383977713e-12
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,22995,1712,1.58 [1.45-1.71],5.0902926354000035e-28
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Pleural effusion,21526,1374,1.74 [1.59-1.90],1.58903217890356e-33
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Pleural plaque,20400,248,1.54 [1.23-1.93],0.0001480178241599
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22582,2295,1.80 [1.68-1.92],2.7511838787060564e-63
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,22997,391,1.67 [1.41-1.98],3.099273581817418e-09
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Pneumothorax,20321,169,1.46 [1.12-1.91],0.0052194450729963
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Pollen allergy,23111,200,0.94 [0.71-1.25],0.6728714642559139
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Pulmonary oedema,22502,93,1.85 [1.33-2.58],0.0002941224241905
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Respiratory insufficiency,14225,71,2.41 [1.67-3.47],2.411071171024031e-06
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22816,1278,1.71 [1.55-1.87],1.4466771493452664e-29
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22066,237,0.96 [0.75-1.24],0.7750200794762004
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Viral pneumonia,20588,301,1.60 [1.31-1.96],4.380763807813731e-06
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22613,240,1.51 [1.21-1.89],0.0003298002101255
TGFA,Protransforming growth factor alpha,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7354,119,1.33 [0.93-1.90],0.1212219977204704
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14623,61,1.67 [1.08-2.58],0.0204957546400434
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Acute appendicitis,23012,128,0.92 [0.65-1.29],0.6143497403467248
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Acute gastritis,16060,104,1.37 [0.97-1.95],0.0761487626216437
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Acute pancreatitis,21076,198,1.59 [1.25-2.02],0.0001522313940616
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Acute peritonitis,22633,113,2.18 [1.64-2.88],6.100693524895086e-08
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22142,63,2.21 [1.52-3.21],3.073011268937434e-05
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Barrett oesophagus,16464,508,1.32 [1.12-1.56],0.0008293107183179
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21023,145,1.51 [1.13-2.01],0.0056649397823448
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22699,145,1.48 [1.10-1.97],0.0086446892673701
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Cholecystitis,21097,219,1.42 [1.12-1.80],0.003421809597549
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Cholelithiasis,21924,1046,1.48 [1.33-1.64],7.215579592429692e-13
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Chronic gastritis,16302,346,1.06 [0.86-1.30],0.6005386416116943
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Chronic pancreatitis,20933,55,0.82 [0.48-1.41],0.4806976579141242
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",22980,126,1.72 [1.28-2.31],0.000343004038022
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Coeliac disease,21377,124,1.70 [1.27-2.30],0.0004418500169334
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Collagenous colitis,21374,104,1.52 [1.09-2.14],0.0147974207610029
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23007,160,1.40 [1.06-1.84],0.0167387478036317
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Constipation,22838,2130,1.34 [1.24-1.45],1.37054675836735e-13
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Crohn disease,21359,89,2.00 [1.43-2.79],5.598740043411744e-05
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22769,68,1.79 [1.22-2.64],0.0032234319554618
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21351,81,2.07 [1.46-2.93],4.013484328004248e-05
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Dental caries,22505,187,1.43 [1.10-1.84],0.0063926518018683
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,19972,2554,1.23 [1.15-1.32],1.871984284065968e-08
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Diseases of appendix,23040,156,0.90 [0.66-1.23],0.5069010021926418
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Diseases of liver,22999,920,1.49 [1.33-1.67],4.170733230913129e-12
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20555,4599,1.23 [1.16-1.30],1.2670692768136105e-13
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22790,472,1.21 [1.03-1.44],0.0227660911088711
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23035,515,1.49 [1.28-1.73],3.169266161281155e-07
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22410,92,0.87 [0.58-1.31],0.5154172497921932
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22283,59,0.89 [0.54-1.48],0.6592975231009688
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22789,1536,1.37 [1.25-1.50],9.71163837194428e-12
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Diseases of tongue,22301,96,1.38 [0.96-1.97],0.0796662204141167
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22397,1519,1.43 [1.31-1.57],2.8508917579407608e-15
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18351,3789,1.24 [1.17-1.32],2.449027165417403e-12
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Duodenal ulcer,16206,250,1.47 [1.18-1.84],0.0007333996767052
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23029,204,1.42 [1.11-1.82],0.0053825902482443
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23087,27,1.92 [1.04-3.57],0.0379001320078741
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22226,147,1.78 [1.36-2.33],2.8012408822093538e-05
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14671,109,1.61 [1.16-2.24],0.0044234252606384
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Functional dyspepsia,16519,563,1.10 [0.94-1.30],0.2213011516227929
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Gastric ulcer,16382,426,1.35 [1.14-1.61],0.0006134957449707
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18627,2671,1.20 [1.12-1.29],5.409403187993486e-07
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16609,653,1.36 [1.18-1.56],2.0424347102967343e-05
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16677,8217,1.19 [1.15-1.25],7.079480909241209e-17
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,GI-bleeding,22531,1278,1.36 [1.24-1.51],7.553447818491734e-10
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22364,46,1.17 [0.68-2.01],0.5768000002825895
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,15561,1191,1.20 [1.07-1.34],0.0013651618831999
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22148,69,2.11 [1.47-3.01],4.2905512594589255e-05
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Hernia,21066,3648,1.16 [1.09-1.23],3.0919618006354773e-06
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Impacted teeth,23090,25,2.13 [1.15-3.97],0.0167837535373416
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Impaction of intestines,14640,78,1.03 [0.66-1.61],0.8835033513190238
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Inguinal hernia,18518,1100,1.05 [0.93-1.18],0.4515243368310775
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",17543,125,1.04 [0.73-1.48],0.8341539902165676
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14680,118,1.40 [1.00-1.95],0.048098805353748
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21396,143,1.49 [1.11-1.99],0.0072785204541638
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,15082,520,1.35 [1.15-1.59],0.0001881739295274
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23091,339,1.56 [1.29-1.87],2.725465921643702e-06
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22056,786,1.62 [1.44-1.82],1.64056972977697e-15
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22365,1095,1.50 [1.35-1.66],1.9542500863861413e-14
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Oesophageal obstruction,16176,220,1.62 [1.29-2.05],4.2728975684689246e-05
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Oesophagitis,16652,696,1.37 [1.19-1.57],5.957532446612658e-06
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23071,135,1.15 [0.84-1.57],0.3985784550985918
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17505,87,2.05 [1.44-2.93],6.771277217327639e-05
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15939,1377,1.19 [1.08-1.32],0.0005294296196038
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21239,361,1.31 [1.09-1.58],0.0046460033095161
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21025,147,1.32 [0.99-1.77],0.0599095662592042
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other diseases of intestine,16493,1931,1.18 [1.09-1.29],9.75537797636924e-05
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other diseases of intestines,20791,6229,1.23 [1.17-1.29],2.775576427803015e-18
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22265,209,1.11 [0.86-1.44],0.4196439515080626
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other diseases of liver,22841,762,1.50 [1.33-1.70],1.3157641077005312e-10
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16724,768,1.33 [1.17-1.52],2.1387812619368423e-05
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21093,215,1.60 [1.27-2.01],7.338683262880328e-05
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22956,436,1.33 [1.12-1.58],0.0011029340070335
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17045,1089,1.46 [1.31-1.63],6.226541461982982e-12
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22548,1295,1.36 [1.23-1.50],1.2886388658379607e-09
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22496,178,1.41 [1.09-1.83],0.0090540629463982
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16736,2174,1.40 [1.30-1.51],6.535129781434149e-18
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18126,2170,1.33 [1.23-1.43],7.941616534697442e-13
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22193,114,1.54 [1.12-2.11],0.0082491622271013
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22236,966,1.54 [1.38-1.72],8.17523791479348e-15
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",15010,448,1.48 [1.25-1.75],4.036712487913875e-06
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23083,31,1.76 [0.97-3.19],0.062722018478703
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,15182,620,1.43 [1.24-1.65],1.1699244523742829e-06
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21412,159,1.70 [1.31-2.20],7.146319455584045e-05
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23111,53,1.20 [0.73-1.98],0.4702654905398192
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22312,103,1.27 [0.90-1.81],0.1759802796642894
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Toxic colitis,21352,82,1.45 [0.98-2.15],0.0610437027734318
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,16302,346,1.33 [1.09-1.61],0.0042275652364548
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Ulcerative colitis,21439,169,1.75 [1.35-2.26],2.1772202736427687e-05
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21404,134,1.69 [1.27-2.26],0.0003509529648456
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Umbilical hernia,17677,259,1.46 [1.17-1.82],0.0009348384742243
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14812,250,1.67 [1.35-2.06],2.521039043286497e-06
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Ventral hernia,17710,292,1.22 [0.99-1.52],0.0653082523739667
TGFA,Protransforming growth factor alpha,Chapter XI Diseases of the digestive system,Volvulus,14655,93,1.19 [0.80-1.76],0.3903166408501894
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23015,429,0.98 [0.81-1.19],0.854272710068041
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,22758,66,1.66 [1.10-2.50],0.0152767533498044
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20556,169,1.06 [0.79-1.42],0.6845382244963127
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22494,830,1.67 [1.49-1.88],9.496914511532782e-18
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21808,144,1.44 [1.08-1.93],0.0142334282780168
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21020,633,1.73 [1.51-1.97],6.237734195533577e-16
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,22777,311,1.48 [1.21-1.80],9.727260701385347e-05
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23022,556,1.59 [1.37-1.83],3.589441874160192e-10
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22515,49,1.79 [1.12-2.87],0.0149935242786432
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21526,3733,1.31 [1.23-1.39],8.3407824409149555e-19
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22691,441,1.16 [0.97-1.38],0.1022397925487041
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22558,308,1.04 [0.84-1.29],0.7092884901434708
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22741,1077,1.58 [1.42-1.75],1.4538277174002966e-17
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23102,60,0.70 [0.41-1.20],0.1949980900092541
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,20445,58,1.86 [1.22-2.83],0.0036340110213729
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22313,63,1.38 [0.89-2.16],0.1547240465573697
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,22763,297,1.49 [1.22-1.83],8.583062049446383e-05
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,20996,609,1.33 [1.14-1.54],0.0001892336025207
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,20477,90,1.10 [0.74-1.64],0.6369703414198703
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23036,99,1.73 [1.24-2.42],0.0012849437046866
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,21898,234,1.87 [1.50-2.32],1.9956917769281048e-08
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,22918,226,1.38 [1.09-1.74],0.0073480729470627
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22564,98,2.23 [1.64-3.03],3.478376080086724e-07
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,20466,79,1.12 [0.74-1.72],0.5891493551261076
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22507,2120,1.40 [1.29-1.51],1.3360131003267649e-17
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21040,653,1.39 [1.21-1.60],4.547478485824687e-06
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,20481,94,1.09 [0.73-1.61],0.681315891218716
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23030,338,1.26 [1.03-1.53],0.0235543892742732
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22538,72,1.60 [1.07-2.39],0.0207453908439597
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,22969,277,1.38 [1.11-1.70],0.0031533259842547
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23048,462,0.94 [0.79-1.13],0.538991930426431
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20514,127,1.00 [0.71-1.41],0.9896529231415964
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20725,338,0.93 [0.75-1.15],0.5019834611428471
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23036,450,0.96 [0.80-1.16],0.6793539509538341
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",20724,337,2.15 [1.82-2.54],1.8664259495512696e-19
TGFA,Protransforming growth factor alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23096,159,1.29 [0.97-1.71],0.0790231815826347
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,19271,81,1.18 [0.78-1.79],0.4233495443350975
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20372,6445,1.22 [1.17-1.28],1.4267935992009565e-17
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,18960,5033,1.20 [1.14-1.27],5.053941291007227e-12
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,19243,53,1.11 [0.66-1.86],0.6947169540763034
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,19172,148,1.53 [1.15-2.03],0.003351590367689
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,19219,195,1.41 [1.10-1.82],0.0077740306109562
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,22861,65,0.80 [0.49-1.31],0.3699987343084016
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",19177,153,1.42 [1.07-1.89],0.0151582908963608
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15406,1479,1.20 [1.08-1.32],0.0003429257689784
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",22912,244,0.93 [0.73-1.20],0.590355541755444
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19609,585,1.12 [0.96-1.31],0.1611150208859902
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18700,8033,1.19 [1.14-1.24],2.3185983786827823e-15
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20578,123,1.18 [0.84-1.64],0.3423443935253332
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,19371,181,1.34 [1.03-1.74],0.0310374814618999
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19693,503,0.99 [0.83-1.17],0.878758881622946
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22185,3161,1.26 [1.18-1.35],1.6168145539373044e-12
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19501,311,0.70 [0.55-0.89],0.0035148905907893
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,19338,148,1.06 [0.78-1.43],0.7301466347836973
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19303,113,0.73 [0.49-1.08],0.112050184438215
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22367,100,1.41 [1.00-2.00],0.0510744079280769
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15940,2013,1.15 [1.05-1.25],0.0016848961752815
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14716,789,2.07 [1.84-2.33],1.4344103721228216e-33
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23026,782,1.98 [1.76-2.23],7.329770721789759e-30
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14005,78,1.34 [0.88-2.03],0.1684268803944855
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14229,302,1.20 [0.96-1.49],0.1054342176622142
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19458,268,1.21 [0.96-1.51],0.1001843406104582
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14415,488,1.04 [0.87-1.25],0.6449437490093219
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,19104,80,1.70 [1.17-2.48],0.0055178460209609
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19711,687,1.31 [1.14-1.51],0.0001060526910696
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,19342,318,1.32 [1.07-1.61],0.0086525989170054
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14383,456,1.02 [0.85-1.23],0.8259351812408404
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,19259,69,1.04 [0.66-1.64],0.8724819863982326
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",19250,60,1.12 [0.69-1.81],0.648597827294563
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20540,85,2.96 [2.15-4.07],3.049675469989521e-11
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22687,2232,1.33 [1.23-1.43],2.113443063142924e-13
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22023,1568,1.37 [1.25-1.50],4.120046556683315e-12
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22952,544,1.62 [1.41-1.88],3.0118559033342206e-11
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,17063,3136,1.32 [1.24-1.41],3.767652402637774e-17
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,13970,43,1.19 [0.67-2.12],0.5606981618077683
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,19295,105,1.33 [0.93-1.89],0.1168170392245273
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,13994,67,1.86 [1.21-2.85],0.0044124938964745
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14063,136,1.40 [1.03-1.90],0.0336348528095471
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20697,242,1.29 [1.02-1.63],0.0344397776773733
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,20966,511,1.29 [1.10-1.51],0.0021188114421732
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23099,115,1.30 [0.93-1.82],0.1240591968097436
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21018,1994,1.31 [1.21-1.42],4.1578296360869e-11
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19265,75,1.18 [0.77-1.82],0.4415952730939826
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14081,154,1.47 [1.10-1.97],0.0084722674894895
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,19819,795,1.31 [1.15-1.49],4.31520152009887e-05
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,16129,2202,1.26 [1.16-1.36],1.836353344076625e-08
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22393,126,1.55 [1.14-2.09],0.0045388413747726
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23111,63,1.64 [1.08-2.49],0.0215388501006829
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19269,79,1.76 [1.23-2.52],0.0020802591359058
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20538,1348,1.36 [1.24-1.50],2.3660361319006855e-10
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,19298,108,1.42 [1.01-2.00],0.0407291619668928
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,15994,2067,1.36 [1.25-1.47],1.1346545633535241e-13
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20570,115,1.49 [1.08-2.07],0.0162541572186301
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,19228,38,1.40 [0.78-2.51],0.2602365234744235
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,19223,199,1.40 [1.09-1.80],0.0092269701123518
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,19877,687,1.62 [1.42-1.84],1.852788662081011e-13
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22759,492,1.51 [1.29-1.76],3.081399599354707e-07
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19684,660,1.45 [1.26-1.66],1.1689321428342636e-07
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22967,538,1.62 [1.40-1.87],5.89942554748465e-11
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23098,69,2.72 [1.99-3.73],4.0942364250744945e-10
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19354,164,1.29 [0.97-1.70],0.0789694473592335
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17992,894,1.46 [1.30-1.64],3.4628301208793956e-10
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19828,638,1.28 [1.11-1.48],0.0006842074328302
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19470,280,0.66 [0.51-0.85],0.0011907856129396
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",13997,70,1.27 [0.81-1.99],0.2944001736712126
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,17043,3116,1.45 [1.36-1.54],1.6039286817088497e-29
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14768,841,1.21 [1.06-1.39],0.0037490676811827
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22643,376,1.50 [1.25-1.80],1.0099514271701836e-05
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23066,82,1.53 [1.05-2.24],0.0278390905769086
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",20458,72,1.03 [0.66-1.59],0.9028065015838872
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,13991,64,1.78 [1.16-2.74],0.008456044942036
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,19132,108,1.15 [0.80-1.64],0.4567826421952843
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14478,551,1.79 [1.55-2.07],2.691927821385357e-15
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19526,336,1.12 [0.91-1.38],0.2728453298572024
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,19313,289,1.52 [1.24-1.87],5.667209710407177e-05
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,19288,264,1.06 [0.84-1.34],0.6048119198444519
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,16240,68,1.92 [1.29-2.86],0.0013222923651919
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23102,73,2.57 [1.88-3.52],4.1099099766700536e-09
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19746,556,1.25 [1.07-1.46],0.0040621658569289
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],22359,92,1.21 [0.83-1.77],0.3173776647981552
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21829,2639,1.18 [1.09-1.26],1.0185686529992738e-05
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19341,151,1.34 [1.01-1.79],0.0448757448229689
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,19743,719,1.18 [1.02-1.35],0.0215409530718409
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,21748,276,1.32 [1.06-1.64],0.0122379655801439
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,19283,259,1.13 [0.90-1.43],0.2953341617115019
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21041,2017,1.27 [1.17-1.38],8.228862292882228e-09
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20337,1313,1.32 [1.19-1.46],6.009472505400841e-08
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],19252,62,1.17 [0.73-1.89],0.511109470042264
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22384,117,1.70 [1.26-2.29],0.0005671570780204
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19351,161,1.00 [0.74-1.35],0.9816506417930342
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,19282,92,1.16 [0.80-1.70],0.4357197075326481
TGFA,Protransforming growth factor alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14003,76,1.26 [0.82-1.93],0.2907248362035685
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21607,2255,2.01 [1.88-2.15],8.294716929393375e-95
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9259,26,0.62 [0.27-1.39],0.2421450695210669
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11746,33,1.05 [0.55-2.02],0.8737944309549941
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22791,312,1.24 [1.01-1.52],0.044484735053071
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22585,106,1.14 [0.79-1.65],0.4859497157637199
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21689,2337,2.23 [2.09-2.38],7.727577330961641e-132
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,22889,131,3.72 [3.06-4.52],1.2892813728182414e-39
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,22810,410,1.42 [1.19-1.69],7.520094396559422e-05
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Cystitis,19252,299,1.15 [0.92-1.42],0.2221964731075009
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Dialysis,19451,99,4.97 [3.93-6.30],2.936553100331668e-40
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10193,2150,1.05 [0.97-1.15],0.2203944371224874
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Disorders of breast,11847,134,1.26 [0.93-1.70],0.1416832350767927
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Endometriosis,9272,39,0.81 [0.43-1.53],0.5204551646920821
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9814,581,1.07 [0.92-1.24],0.4064494800324597
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19045,6302,1.37 [1.30-1.43],3.8502815525502576e-40
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,22856,98,3.10 [2.39-4.04],2.3470522442156485e-17
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Hydrocele,8162,119,0.79 [0.54-1.17],0.2444133966910667
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,19424,353,1.49 [1.23-1.80],4.861445126709596e-05
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9873,1830,1.06 [0.96-1.16],0.2380220993741215
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,11917,161,1.31 [0.99-1.72],0.0563203272078788
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8170,127,1.01 [0.71-1.44],0.9679211107058208
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,19040,87,1.52 [1.05-2.21],0.0280133751603989
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10265,1032,1.12 [1.00-1.25],0.0579806317918964
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,8106,63,0.96 [0.58-1.60],0.8822230391207079
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9273,40,1.43 [0.83-2.47],0.1957877011623234
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23108,88,1.45 [1.00-2.10],0.0509367406914422
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23109,84,1.21 [0.81-1.80],0.3469806769190247
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21921,2968,1.37 [1.28-1.46],1.2709855939439914e-20
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,19895,942,1.17 [1.03-1.33],0.0125242222233935
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11764,51,1.47 [0.91-2.35],0.1126842861142579
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23034,634,1.54 [1.35-1.77],4.68608817344679e-10
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8197,154,1.46 [1.09-1.96],0.0118285504618463
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8205,162,1.22 [0.90-1.66],0.1899846433496994
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,8196,153,0.57 [0.40-0.82],0.0020344905747205
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23081,86,1.49 [1.03-2.15],0.0345620312072206
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21320,2367,1.52 [1.41-1.63],2.4384111871952448e-30
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11839,83,1.32 [0.90-1.94],0.152614848238836
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9302,69,0.84 [0.52-1.36],0.4793417588556657
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9373,140,1.17 [0.86-1.59],0.3068955424215232
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9287,54,1.66 [1.05-2.62],0.0294702950451858
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9334,101,0.75 [0.50-1.11],0.1487987271573261
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19487,416,1.54 [1.30-1.84],1.0995297282924194e-06
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22603,203,1.63 [1.28-2.06],5.881065873678083e-05
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9359,126,1.10 [0.79-1.53],0.557891463579152
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9258,25,1.48 [0.75-2.93],0.2568205049708064
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9443,210,1.00 [0.77-1.29],0.989048974927035
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9327,94,1.12 [0.77-1.63],0.5422924968740095
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9437,204,0.82 [0.62-1.07],0.1477237557882496
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,22806,48,1.44 [0.87-2.39],0.1553208786148085
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8199,156,1.12 [0.82-1.53],0.4774803706353119
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22831,3760,1.86 [1.76-1.96],1.1222096627442818e-115
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",19165,94,2.02 [1.44-2.83],4.0957750531825546e-05
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19533,181,3.09 [2.52-3.79],1.247076263370794e-27
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22518,39,0.69 [0.36-1.34],0.2771398035841407
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Urethral stricture,19224,271,1.38 [1.11-1.72],0.0040354290231443
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22878,399,1.15 [0.95-1.39],0.141486554068436
TGFA,Protransforming growth factor alpha,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9270,37,0.83 [0.44-1.58],0.5678275687266114
